Literature DB >> 2963815

Two molecular forms of the human interferon-gamma receptor. Ligand binding, internalization, and down-regulation.

D G Fischer1, D Novick, P Orchansky, M Rubinstein.   

Abstract

The receptors for human interferon-gamma (IFN-gamma) on peripheral blood monocytes and various cells of nonhematopoietic origin were thoroughly characterized and compared. The receptors of all cell types exhibited a similar affinity for IFN-gamma (Kd approximately 1 x 10(-10) M), and in all cases receptor-mediated endocytosis and ligand degradation were demonstrated. However, the receptors differed in their molecular weights (95,000 in HeLa cells and 140,000 in monocytes, assuming a 1:1 ligand to receptor ratio) as concluded from experiments of cross-linking to 125I-IFN-gamma. Lower molecular weight species were obtained as well, particularly in monocytes. Such species could represent either degradation products or subunit structures. The monocyte and HeLa receptor responded differently to an excess of ligand. A significant receptor down-regulation was observed when monocytes were incubated with an excess of 125I-IFN-gamma, whereas no such down-regulation was observed in HeLa cells or in normal fibroblasts. This differential response was observed both in the presence or in the absence of a protein synthesis inhibitor. The receptor on monocytes was found to be acid-labile whereas that on HeLa cells was resistant to acid treatment. These and additional experiments indicate that the monocyte receptor is inactivated following internalization, whereas the HeLa receptor retains its structure and recycles back to the cell surface. The difference in the properties and fate of these two receptor subtypes is probably related to the differential functions of IFN-gamma in various cell types.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2963815

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Cytokines activate genes of the endocytotic pathway in insulin-producing RINm5F cells.

Authors:  K L A Souza; M Elsner; P C F Mathias; S Lenzen; M Tiedge
Journal:  Diabetologia       Date:  2004-07-10       Impact factor: 10.122

2.  Vaccinia virus blocks gamma interferon signal transduction: viral VH1 phosphatase reverses Stat1 activation.

Authors:  P Najarro; P Traktman; J A Lewis
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Gamma interferon primes productive human immunodeficiency virus infection in astrocytes.

Authors:  Deborah Carroll-Anzinger; Lena Al-Harthi
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Post-translational modification of the interferon-gamma receptor alters its stability and signaling.

Authors:  James D Londino; Dexter L Gulick; Travis B Lear; Tomeka L Suber; Nathaniel M Weathington; Luke S Masa; Bill B Chen; Rama K Mallampalli
Journal:  Biochem J       Date:  2017-10-10       Impact factor: 3.857

5.  Regulation of cell-surface receptors for human interferon-gamma on the human histiocytic lymphoma cell line U937.

Authors:  D S Finbloom
Journal:  Biochem J       Date:  1991-03-15       Impact factor: 3.857

6.  The extracellular domain of the human interferon gamma receptor interacts with a species-specific signal transducer.

Authors:  V C Gibbs; S R Williams; P W Gray; R D Schreiber; D Pennica; G Rice; D V Goeddel
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

7.  Positive and negative cooperativity of TNF and Interferon-γ in regulating synovial fibroblast function and B cell survival in fibroblast/B cell co-cultures.

Authors:  Torsten Lowin; Tareq M Anssar; Marina Bäuml; Tim Classen; Matthias Schneider; Georg Pongratz
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.